Jaka jest cena za Dechra Pharmaceuticals PLC (DPH)

Cena za Dechra Pharmaceuticals PLC (DPH) wynosi $52.60

Jaka jest kapitalizacja rynkowa dla Dechra Pharmaceuticals PLC (DPH)

Kapitalizacja rynkowa dla Dechra Pharmaceuticals PLC (DPH) wynosi $59.92M

Dechra Pharmaceuticals PLC (DPH) Marża Operacyjna

Dechra Pharmaceuticals PLC is a veterinary-focused enterprise dedicated to the development, production, regulatory approval, marketing, and distribution of animal health products and associated goods for veterinarians. The company's activities are organized across three key segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. It supplies a broad range of veterinary treatments, encompassing endocrinology, dermatology, pain management and anesthetics, cardiovascular therapies, and critical care solutions for dogs and cats. For poultry, pigs, and cattle, offerings include water-soluble antibiotics, avian vaccines, and pain relief products. Equine health is addressed with products for lameness and pain. Furthermore, Dechra offers specialized pet nutrition designed to support therapeutic conditions in cats and dogs, such as allergies, obesity, and heart or kidney diseases. Its diversified operations also involve the distribution of veterinary pharmaceuticals and equipment, the provision of financial services, the promotion of pet food, and the creation, regulation, manufacturing, and commercialization of crop protection items. The company’s merchandise is primarily channeled to customers via extensive wholesaler and distributor networks. Founded in 1997 and headquartered in Northwich, UK, Dechra Pharmaceuticals PLC operates globally, with a significant presence in the United Kingdom, Germany, across Europe, the United States, and international markets.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
Eli Lilly and Company LLY.US	43.92%	-	US
Johnson & Johnson JNJ.US	26.81%	-	US
AbbVie Inc. ABBV.US	29.32%	-	US
Roche Holding AG RO.SW	26.59%	-	CH
Merck & Co., Inc. MRK.US	16.65%	-	US

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj